Pfizer hair loss drug Litfulo approved in UK
Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.
Bengaluru: Britain's medicines regulator has approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease.The drug, branded as Litfulo, has been approved by UK's Medicines and Healthcare products Regulatory Agency (MHRA) for people aged 12 years and older suffering from severe alopecia areata.It has already been approved for use in Europe and the United States.Read also:...
Login or Register to read the full article
Bengaluru: Britain's medicines regulator has approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease.
The drug, branded as Litfulo, has been approved by UK's Medicines and Healthcare products Regulatory Agency (MHRA) for people aged 12 years and older suffering from severe alopecia areata.
It has already been approved for use in Europe and the United States.
Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps
Read also: Hair loss drug: Pfizer Litfulo for adults, adolescents approved by USFDA
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd